Drug Information

Drug General Information
Drug ID
D05ICF
Former ID
DNC014569
Drug Name
1,3-Di-p-tolyl-[1,3]diazetidine-2,4-dione
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526092]
Formula
C16H14N2O2
Canonical SMILES
CC1=CC=C(C=C1)N2C(=O)N(C2=O)C3=CC=C(C=C3)C
InChI
1S/C16H14N2O2/c1-11-3-7-13(8-4-11)17-15(19)18(16(17)20)14-9-5-12(2)6-10-14/h3-10H,1-2H3
InChIKey
AZZFGWWOGRBVOV-UHFFFAOYSA-N
PubChem Compound ID
3492365
Target and Pathway
Target(s) Trypsin Target Info Inhibitor [526092]
KEGG Pathway Neuroactive ligand-receptor interaction
Pancreatic secretion
Protein digestion and absorption
Influenza A
Reactome Activation of Matrix Metalloproteinases
Cobalamin (Cbl, vitamin B12) transport and metabolism
WikiPathways Activation of Matrix Metalloproteinases
References
Ref 526092Bioorg Med Chem Lett. 2001 Jul 9;11(13):1691-4.Inhibition of serine proteases: activity of 1,3-diazetidine-2,4-diones.
Ref 526092Bioorg Med Chem Lett. 2001 Jul 9;11(13):1691-4.Inhibition of serine proteases: activity of 1,3-diazetidine-2,4-diones.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.